Deputy General Director of WHO, Mr. Keiji Fukuda, that we are still in the first phase of the epidemic caused by virus A H1N1, and perhaps the most difficult period ahead.
WHO estimates that can be two billion people worldwide will be affected by this infection in two years. . Just four months after starting to appear in Mexico, influenza A virus H1N1 has now rapidly spread virtually throughout the world. Now has up to 160 of 193 member countries of WHO has been concerned by the new flu. By Gregory Hartl, a spokesman for the WHO, has about 800 cases of death of hundreds of thousands of people have been infected this flu virus.
Although the mortality rate seems low, but this certainly is not statistics accurately. This new virus, very easy to cause infection, the majority of cases cause only mild disorders can not be identified. However, there is a low rate of severe cases even up to date statistics are not yet clearly. Người phát ngôn của WHO spokesman stated that "the more severe cases will more death."
These threats can not consider
We now have two threats. The first threat is the threat of disease activity was reported before and seems inevitable, in September to this, the risk of the disorder is primarily social - economic (the importance still difficult to assess all) if several employees to eat food infected simultaneously. And surely there is a certain mortality rate, even though still limited.
Threats, there is a mutation of H1N1 virus into a form more complex and pathogenic, and when the number of deaths may be more. Think back, battle flu pandemic in 1918 caused millions of people died, was first reported by a flu epidemic in the summer is relatively benign. However, the battle pandemic in 1957 and 1968 have not known a situation like that, and the virus was not pathogenic mutation to become more pathogenic. WHO spokesman said: "Need to know may have changed, and we must be willing to confront it. Up to now we have not seen a change in the behavior of the virus. What we observed, only the expansion of its geographical location.
With the hypothesis of such a surge, the effectiveness of vaccines being Dosage will be like? There is not one can answer this question. But we know that the Battle of the epidemic in 1918, those, which have been infected during the summer to be a benign disease, there was a certain immunity to the virus became pathogenic than.
Priority for poor countries
Although WHO has stopped the inventory number of H1N1 cases because they believe that these numbers are unreliable, but they still call the country continue to report cases of death were the lab confirmed.
Gregory Hartl, WHO spokesman, said several pharmaceutical companies have begun conducting clinical trials vawcxin influenza A H1N1. He said there are two major pharmaceutical companies have promised to contribute 150 million doses of vaccines to the WHO. The organization also is working with many different partners to get more vaccines for developing countries
Newer news items:
- 17/08/2009 01:12 - Hpai H1N1 began drug Tamiflu resistance
- 17/08/2009 01:07 - Have storage area phenomenon in the drug Tamiflu
Older news items:
- 08/08/2009 03:24 - NÊN TRÁNH NHỮNG NƠI ĐÔNG NGƯỜI ĐỂ ĐỀ PHÒNG TRÁNH CÚM A/H1N1
